• 1
    Festi D, Colecchia A, Sacco T, Bondi M, Roda E, Marchesini G. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes. Rev. 2004; 5: 2742.
  • 2
    Hickman IJ, Powell EE, Prins JB et al. In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. J. Hepatol. 2003; 39: 10428.
  • 3
    Bressler BL, Guindi M, Tomlinson G, Heathcote J. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. Hepatology 2003; 38: 63944.
  • 4
    Hickman IJ, Clouston AD, Macdonald GA et al. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut 2002; 51: 8994.
  • 5
    Ueno T, Sugawara H, Sujaku K. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J. Hepatol. 1997; 27: 1037.
  • 6
    Bandura A. Social Foundations of Thoughts and Action. New Jersey: Prentice Hall, 1986.
  • 7
    Nir Z, Neumann L. Relationship among self-esteem, internal-external locus of control, and weight change after participation in a weight reduction program. J. Clin. Psychol. 1995; 51: 48290.
  • 8
    Prochaska J, Di Clemente C. Stages and processes of self-change of smoking: toward an integrative model of change. J. Consult. Clin. Psychol. 1983; 51: 3905.
  • 9
    Becker M. The Health Belief Model and Personal Health Behaviour. New Jersey, USA: Charles B Slack, 1974.
  • 10
    Ulijaszek SJ, Kerr DA. Anthropometric measurement error and the assessment of nutritional status. Br. J. Nutr. 1999; 82: 16577.
  • 11
    Klein S, Sheard NF, Pi-Sunyer X et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am. J. Clin. Nutr. 2004; 80: 25763.
  • 12
    Lantz H, Peltonen M, Agren L, Torgerson J. A dietary and behavioural programme for the treatment of obesity. A 4-year clinical trial and a long term posttreatment follow-up. J. Internal Med. 2003; 254: 2729.
  • 13
    Pritchard DA, Hyndman J, Taba F. Nutritional counselling in general practice: a cost effective analysis. J. Epidemiol. Community Health 1999; 53: 31116.
  • 14
    Marks G, Coyne T, Pang G. Type 2 Diabetes Costs in Australia – The Potential Impact of Changes in Diet, Physical Activity and Levels of Obesity. National Food and Nutrition Monitoring and Surveillance Project. Canberra: Commonwealth Department of Health and Aged Care, 2002.
  • 15
    Huang MA, Greenson JK, Chao C et al. One-year intense nutritional counseling results in histological improvement in patients with nonalcoholic steatohepatitis: a pilot study. Am. J. Gastroenterol. 2005; 100: 107281.
    Direct Link:
  • 16
    Hickman IJ, Jonsson JR, Prins JB et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 2004; 53: 41319.
  • 17
    Adinolfi LE, Gambardella M, Adreana A, Tripodi M, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33: 135864.
  • 18
    Stranges S, Dorn JM, Paola M et al. Body fat distribution, relative body weight, and liver enzyme levels: a population-based study. Hepatology 2004; 39: 75463.
  • 19
    Manson JE, Skerrett PJ, Greenland P, VanItallie TB. The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians. Arch. Intern. Med. 2004; 164: 24958.